- $4.40bn
- $7.33bn
- $3.03bn
- 69
- 59
- 21
- 48
2020 February 1st | 2021 January 30th | 2022 January 29th | 2023 January 28th | 2024 February 3rd | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,647 | 2,849 | 3,759 | 3,590 | 3,029 |
Cost of Revenue | |||||
Gross Profit | 1,095 | 1,326 | 1,855 | 1,812 | 1,389 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,291 | 2,402 | 2,861 | 3,038 | 2,663 |
Operating Profit | 356 | 447 | 898 | 553 | 366 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 269 | 377 | 830 | 439 | 167 |
Provision for Income Taxes | |||||
Net Income After Taxes | 220 | 273 | 697 | 531 | 138 |
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 220 | 272 | 689 | 529 | 128 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 220 | 272 | 689 | 529 | 128 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 9.76 | 11.3 | 23 | 18.1 | 6.6 |